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Mucosal-associated invariant T (MAIT) cells play an
important physiological role in host pathogen
defense and may also be involved in inflammatory
disorders and multiple sclerosis. The rarity and inef-
ficient expansion of these cells have hampered
detailed analysis and application. Here, we report
an induced pluripotent stem cell (iPSC)-based re-
programming approach for the expansion of func-
tional MAIT cells. We found that human MAIT cells
can be reprogrammed into iPSCs using a Sendai
virus harboring standard reprogramming factors.
Under T cell-permissive conditions, these iPSCs effi-
ciently redifferentiate into MAIT-like lymphocytes
expressing the T cell receptor Va7.2, CD161, and
interleukin-18 receptor chain a. Upon incubation
with bacteria-fed monocytes, the derived MAIT cells
show enhanced production of a broad range of
cytokines. Following adoptive transfer into immuno-
compromised mice, these cells migrate to the bone
marrow, liver, spleen, and intestine and protect
against Mycobacterium abscessus. Our findings
pave the way for further functional analysis of MAIT
cells and determination of their therapeutic potential.
INTRODUCTION
Pluripotent embryonic stem cells (ESCs) and induced pluripotent
stem cells (iPSCs) hold great promise for regenerative medicine546 Cell Stem Cell 12, 546–558, May 2, 2013 ª2013 Elsevier Inc.because, in principal, they can give rise all types of cells in the
body. Realizing the potential of ESC- or iPSC-based cell therapy
for regenerative medicine requires a highly homogeneous
population of somatic stem cells or functionally competent
differentiated cells derived from ESCs or iPSCs (Kiskinis and
Eggan, 2010; Lengner, 2010; Murry and Keller, 2008; Robinton
and Daley, 2012). However, the immunocompatibility of ESCs
is a barrier to regenerative medicine. The advent of iPSC tech-
nology has made it possible to procure a patient’s own iPSCs
(Kiskinis and Eggan, 2010; Lengner, 2010; Robinton and Daley,
2012). Current techniques for reprogramming somatic cells
into a pluripotent state depend largely on the introduction of re-
programming factors such as OCT3/4, SOX2, KLF4, c-MYC,
and/or LIN-28 into the genome (Lengner, 2010; Robinton and
Daley, 2012). Retroviral transfer of these genes could culminate
in increased incidence of tumor development and/or cellular
dysfunction due to both the intrinsic nature of these factors as
oncogenes and concomitant genomic modification (Lengner,
2010). In contrast, Sendai virus (SeV) is an ideal vector for re-
programming cells into a pluripotent state without modifying
the genome, and thus would be suitable for regenerative medi-
cine (Fusaki et al., 2009; Nishimura et al., 2011; Seki et al., 2010).
Many efforts have concentrated on directed differentiation of
the desired cell type from ESCs and iPSCs. Among many
different cell types induced from ESCs and iPSCs, the clonality
of cells may be followed in lymphocytes expressing a defined
T or B cell receptor (TCR or BCR) model system that allows for
rigorous assessment of their intrinsic functions. T cells are largely
categorized into either CD4+ or CD8+ conventional T cells and
invariant T cells. The TCR combination in conventional T cells
is unlimited and optimized to adaptive immunity, whereas that
of invariant T cells is limited and suited for innate immunity.
Mucosal-associated invariant T (MAIT) cells are a subset of the
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in that they express an invariant Va7.2-Ja33 in human (Va19-
Ja33 in mouse) as TCRa, CD161 as a marker for natural killer
(NK) cells, and the interleukin-18 receptor chain a (IL-18Ra) for
T helper 17 (Th17) cells (Cosmi et al., 2008; Le Bourhis et al.,
2010). MAIT cells rarely express CD4 but are CD8ab+, CD8aa+,
or double negative (Le Bourhis et al., 2011; Martin et al., 2009;
Walker et al., 2012). MAIT cells are abundant in humans, repre-
senting up to 50% of the resident T cells in the liver, 10% of
the T cells in lamina-propria lymphocytes (LPLs), and 10% of
the peripheral blood mononuclear cells (PBMCs). In mice,
however, these cells are quite rare (Dusseaux et al., 2011; Le
Bourhis et al., 2011). The development of MAIT cells depends
on themajor histocompatibility complex (MHC)-relatedmolecule
1 (MR1), but not on MHC molecules as is the case with con-
ventional T cells. Furthermore, MAIT cell-specific TCRa and
MR1 are phylogenetically conserved and are activated in
amanner independent of the transporter associated with antigen
processing and presentation (Le Bourhis et al., 2011; Tilloy et al.,
1999). MAIT cells also harbor a mucosal homing phenotype,
and their development is dependent on commensal flora in the
intestine (Dusseaux et al., 2011; Le Bourhis et al., 2011; Treiner
et al., 2003).
MAIT cells play a pivotal role in host defense against a wide
range of bacterial and fungal infection, but not against viral
infection, though the precise mechanism underlying this has
yet to be elucidated (Chua et al., 2012; Dusseaux et al.,
2011; Georgel et al., 2011; Le Bourhis et al., 2010). MAIT cells
have been identified as Mycobacterium tuberculosis (Mtb)-re-
acting nonconventional CD8+ T cell clones in humans (Gold
et al., 2010). Importantly, MAIT cells are the only T cells that
enhance production of interferon g (IFNg) when cultured with
bacteria-fed monocytes (Le Bourhis et al., 2010). Furthermore,
MAIT cell activation and the production of IFNg have little
dependence on Toll-like receptor (TLR) signaling but are
contingent upon MR1-elicited signaling (Gold et al., 2010; Le
Bourhis et al., 2010). A recent study demonstrated that vitamin
B metabolites are MR1 ligand(s), although the biological signif-
icance has yet to be explored (Kjer-Nielsen et al., 2012). In
addition, several studies have reported a tight correlation
between CD8+CD161hi T cells and MAIT cells. CD8+CD161hi
T cells are enriched at inflammatory regions in the liver and
joints and are presumed to be pathogenic in multiple sclerosis
(MS) (Annibali et al., 2011; Billerbeck et al., 2010). It has been
shown that more than 90% of CD8+CD161hi T cells comprise
MAIT TCRa-specific Va7.2+ cells in adult PBMCs (Walker
et al., 2012).
Given that MAIT cells are abundant in humans, play a protec-
tive role against Mtb infection, and may be vital for MS and
inflammation, it is essential to analyze their function in detail
for exploiting more efficacious vaccine or causal treatments for
these diseases. However, progress has been hindered by the
rarity of MAIT cells in mice and because their expansion
in vitro cannot be induced by any known T cell stimulant (Dus-
seaux et al., 2011). In this report, we show that iPSCs can be
generated from human MAIT cells with an SeV vector harboring
all reprogramming factors and that MAIT-like cells can be
efficiently induced from these iPSCs. Such redifferentiated
MAIT-like cells (reMAIT cells) were free from genomic modifica-tion and ectopic gene expression, and they were functional in
that they produced an array of cytokines and chemokines
upon stimulation or bacterial infection in vitro and protected
mice from Mycobacterium abscessus (M. abscessus) burden
in vivo.
RESULTS
Generation of iPSCs from Cord-Blood MAIT Cells
For establishing iPSCs, MAIT cells were purified from fresh
cord blood (CB) with the monoclonal antibody 3C10, recog-
nizing Va7.2+ cells (Martin et al., 2009). These cells were in-
fected with the SeV vector KOSM302L carrying the reprogram-
ming-factor genes KLF4, OCT3/4, SOX2, and c-MYC
(Nishimura et al., 2013). We obtained more than 55 iPSCs
from three donors, and the origin of these iPSCs was verified
by PCR using a primer set designed to detect the rearranged
Va7.2 and Ja33 in iPSC genomic DNA (Figure 1A; Tables S1
and S2 available online). Sequencing of the resultant PCR
products confirmed such a rearrangement (data not shown).
We used iPSC clones 1-3D, 2-5D, and 4-6D to demonstrate
the pluripotency in the following experiments. Immunofluores-
cence microscopy confirmed expression of pluripotent stem
cell markers such as alkaline phosphatase (ALP), Oct3/4,
Nanog, SSEA4, TRA-1-60, and TRA-1-81 in iPSCs (Figures
1B, S1A, and S1B). These iPSCs harbored telomerase activity
that is normally linked to immortalized cells, such as cancer
cells, but not to normal cells (Figure S1C). Analysis of OCT3/4
and NANOG promoter methylation revealed that these regions
were demethylated upon reprogramming into a pluripotent
state (Figures 1C and S1D and Table S1). RT-PCR analyses
confirmed the expression of transcripts relevant to pluripotency
in iPSCs, of a profile similar to that of human ESCs, but not in
MAIT cells (Figure 1D and Table S1). Expression of the SeV
vector was below the detection limit when iPSC colonies
were subjected to PCR (data not shown). In vitro differentiation
of iPSCs resulted in the expression of three germ-layer cell
markers, including a-smooth-muscle actin (aSMA), Nestin,
and Sox17—a mesoderm, ectoderm, and endoderm marker,
respectively (Figures 1E and S1E). Injection of iPSCs into
immunocompromised mice resulted in the formation of tera-
tomas that consisted of derivatives of the three embryonic
germ layers—melanin-containing cells of ectoderm origin, cyto-
keratin-positive cells of endoderm origin, and desmin-positive
cells of mesoderm origin—as evidenced by immunohisto-
chemistry (Figure 1F). Scatter-plot analysis revealed a tight
correlation in terms of gene expression between MAIT cell-
derived iPSCs (MAIT-iPSCs) and iPSCs derived from human
skin fibroblasts (201B7), as well as MAIT-iPSCs and human
ESCs (khES3) (Figure 2) (Takahashi et al., 2007). The correlation
coefficient (r) between MAIT-iPSCs and 201B7 or khES3 was
0.97 (Figures 2 and S2A). This indicates that the difference
in the gene-expression profile between MAIT-iPSC clones is
no greater than that between MAIT-iPSCs and 201B7/khES3.
Heatmap analysis showed that the gene-expression profiles
of MAIT-iPSCs were similar overall to those of 201B7 and in
khES3 but different from that of MAIT cells from CB (CB-
MAIT cells) (Figure S2B). These data confirm the pluripotency
of MAIT-iPSCs.Cell Stem Cell 12, 546–558, May 2, 2013 ª2013 Elsevier Inc. 547
Figure 1. Characterization of MAIT-iPSCs
(A) Schematic representation of the genomic configuration of the TCRVa7.2 and Ja33 fragments before and after gene rearrangement. The arrows indicate the
primer sets used to detect the rearranged configuration. PCR products (282 bp) were subcloned into a TA vector, and the insert DNA sequences were verified.
(B) MAIT-iPSC colonies exhibit a morphology similar to that of human ESCs and express pluripotency markers, ALP, Oct3/4, Nanog, SSEA4, TRA-1-60, and
TRA-1-81, as evidenced by immunofluorescence staining. Nuclei are stained with DAPI. The scale bar represents 100 mM.
(C) Methylation analysis of OCT3/4 and NANOG promoters in MAIT cells, human ESCs, and MAIT-iPSCs (1-3D, 2-5D, and 4-6D). Genomic DNA from CB-MAIT
cells, khES3, 1-3D, 2-5D, and 4-6D was subjected to bisulfite modification. The promoter regions ofOCT3/4 and NANOG were amplified by PCR with the primer
sets described in Table S1, and methylation states were analyzed. Open and filled circles show nonmethylated and methylated CpG dinucleotides, respectively.
(D) Semiquantitative RT-PCR assay of the pluripotent markers. Complementary DNA from CB-MAIT cells, 1-3D, 2-5D, 4-6D, and khES3 was used as a template.
(E) In vitro differentiation of 1-3D, 2-5D, and 4-6D. Immunofluorescence analysis of 1-3D, 2-5D, and 4-6D demonstrating all three germ layers after embryoid-body
differentiation: mesoderm (a-SMA), ectoderm (nestin), and endoderm (SOX17). Nuclei are stained with DAPI. The scale bar represents 100 mM.
(legend continued on next page)
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Figure 2. Global Gene-Expression Analysis
of MAIT-iPSCs
Scatter plots of global gene-expression profiles of
CB-MAIT cells and MAIT-iPSC clones 1-3D, 2-5D,
and 4-6D (upper panel), between 201B7 and 1-3D,
2-5D, and 4-6D (middle panel), and between
khES3 and 1-3D, 2-5D, and 4-6D (lower panel).
The green line indicates a 5-fold difference in
gene-expression levels between paired cells, and
the dotted line represents the diagonal axis. r
represents the relative correlation coefficient. The
transcript expression levels are on a log10 scale.
See also Figure S2 and Table S2.
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The two-step protocol for induction of MAIT-like cells from
MAIT-iPSCs is shown in Figure 3A. The first step was induction
of lymphocyte precursor cells on the stromal cell line OP9,
and the second was induction of a T cell lineage on OP9
ectopically expressing the notch ligand delta-like 1 (DL1),
designated OP9/DL1 (Schmitt et al., 2004). Among the 55
MAIT-iPSCs, 1-3D was used as a representative clone in the
following experiments. The lymphocyte precursor cells were
identified and purified with human CD34 and CD43 antibodies
and cells seeded on OP9/DL1 for up to 30 days. When evaluated
by fluorescence-activated cell sorting (FACS), the percentage
of lymphocytes recognized by 3C10 and TCRab antibodies
increased with differentiation, and >98% of the putative
total lymphocytes were positive for 3C10 and TCRab by the
end of culture (Figure 3B). When 3C10+TCRab+ cells were gated
and analyzed, the majority expressed IL-18Ra and CD161,
a hallmark of MAIT cells (Le Bourhis et al., 2010). A similar
FACS profile was seen when other MAIT-iPSC clones
from various donors were differentiated under the same condi-
tions (FigureS3A). Thesedata indicate that lymphocytesdifferen-
tiated from MAIT-iPSCs were recognized as MAIT cells; these(F) In vivo pluripotency of MAIT-iPSCs. Teratoma formation 10–12 weeks after transplantation of 1-3D, 2-5D,
sections of identified cells after hematoxylin and eosin and diaminobenzidine staining represent all three
endoderm (cytokeratin-positive cells), and mesoderm (desmin-positive cells). Low- and high-magnification i
See also Figure S1 and Tables S1 and S2.
Cell Stem Cell 12, 546are hereafter designated as reMAIT
cells. reMAIT cells also expressed
CD45RA and CD4 (Figure 3B). For distin-
guishing reMAIT cells from PBMC-
resident MAIT (PBMC-MAIT) cells, core-
ceptor expression was assessed by
FACS (Figures 3C–3E and S3B–S3D).
PBMC-MAIT cells represent an effector
memory phenotype, i.e., CD45RO+
CD62LloCD122intCD127hiCD95hi, where-
as reMAIT cells expressed CD45RA+
CD62LintCD122loCD127intCD95hi at the
end of differentiation (Dusseaux et al.,
2011) (Figures 3B, 3E, and S3D). Expres-
sion of the chemokine receptors CCR5
and CCR6 also increased as cells differ-
entiated, whereas other receptors didnot (Figures 3C and S3B). Furthermore, CD8a increased with
differentiation, whereas CD5, CD8b, and CD243 (ABCB1), an
efflux pump present at high levels in stem cells, did not (Figures
3D and S3C). Expression of CD26, a dipeptidase involved in the
processing of several chemokines and peptidic mediators, was
evident and remained high (Figure 3D) (Liu et al., 2009). NK
markers such as NKG2D and NKp80, present in most memory
CD8+ T cells, and CD150 remained low (Figures 3D and S3C)
(Dusseaux et al., 2011). In contrast, CD244, a signaling lympho-
cyte activation molecule (SLAM) family member like CD150,
exhibited strong expression (Figure 3D). As for costimulatory
molecules, reMAIT cells harbored a moderate level of inducible
costimulatory molecule (ICOS) but a low level of expression of
CD27 and CD28 (Figures 3E and S3D). There was also little
expression of cytokine receptors such as CD25, IL-2Ra, and
CD122 (IL-2Rb), but a low level of CD127 (IL-7Ra) was detected
at the end of differentiation (Figures 3E and S3D). Finally, the
naive marker CD62L and T cell effector molecule Fas (CD95)
were identified (Figure 3E). The high-level expression of CCR5,
CCR6, CD26, CD95, and CD244 and the low-level expression
of CCR9, CD25, and CD122 in reMAIT cells at the end of culture
mirrored that of PBMC-MAIT cells (Dusseaux et al., 2011). Inand 4-6D in NOD/SCID mice is shown. Histological
germ layers: ectoderm (melanin-containing cells),
mages are shown.
–558, May 2, 2013 ª2013 Elsevier Inc. 549
Figure 3. Differentiation of reMAIT Cells from MAIT-iPSCs
(A) Schematic representation of the differentiation protocol. MAIT-iPSCs were induced to give rise to lymphoid precursor cells on OP9. CD34+ and CD34+CD43+
cells were further differentiated on OP9/DL1.
(B) Time course of reMAIT cell generation from MAIT-iPSCs. FACS analysis of the lymphocytes harvested at the indicated times on OP9/DL1 is shown. The
numbers show the percentages of 3C10+TCRab+ cells (upper panel). The expression profile of IL-18Ra, CD161, CD45RA, and CD4 in the 3C10+TCRab+-gated
populations is shown (middle and lower panels).
(C–E) Time course of coreceptor expression in 3C10+TCRab+ cells. 3C10+TCRab+-gated populations at the indicated times were further analyzed in terms of
the expression of CD45RA and the indicated coreceptors. (C) CCR5, CCR6, CXCR3, and CXCR5 expression profiles. (D) CD8a, CD26, NKG2D, NKp80,
and CD244 expression profiles. (E) ICOS, CD25, CD127, CD62L, and CD95 expression profiles. The numbers in the quadrant show the percentages of the
populations.
See also Figure S3.
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Figure 4. Global Gene-Expression Analyses of reMAIT Cells during
Differentiation
(A) PCA of global gene-expression profiles among 1-3D and reMAIT cells
harvested at the indicated days, as well as CB-MAIT cells. The color range
indicates the relative coefficient.
(B) Scatter plots of global gene-expression profiles of 1-3D and the paired cell
populations (reMAIT cells harvested on the indicateddays, andCB-MAIT cells).
(C) Scatter plots of global gene-expression profiles of CB-MAIT cells and
paired cell populations (1-3D and reMAIT cells harvested on the indicated
days). The green line indicates a 5-fold difference in gene-expression level
between the paired cells, and the dotted line represents the diagonal axis.
r represents the relative correlation coefficient. Transcript expression levels
are on a log10 scale.
See also Figure S4.
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ICOS, NKG2D, and NKp80 did not, implying a difference in cell
maturity (Dusseaux et al., 2011; Le Bourhis et al., 2010). Further-
more, we noted that reMAIT cells did not proliferate as well as
cells differentiated onOP9/DL1did. Annexin Vor carboxyfluores-
cein diacetate succinmidyl-ester staining revealed that few cells
died or proliferated during differentiation (data not shown).
Global Gene-Expression Analysis of reMAIT Cells
The differentiation of reMAIT cells was further analyzed using
DNA microarrays. Global gene expressions of reMAIT cells
harvested at various time points were compared with either
each other or with that of 1-3D and CB-MAIT cells. Principal-
component analysis (PCA) revealed that global gene-expression
profiles among reMAIT cell samples beyond day 4 were similar,
though that of 1-3D and day 0 samples differed from those of
the other samples (Figure 4A). Scatter-plot analysis revealed
that the r value of gene expression in 1-3D and CB-MAIT cells
was 0.807 (Figure 4B). Remarkably, the longer reMAIT cells
were incubated, the less they resembled the expression profile
of 1-3D, as evidenced by lower r values (Figure 4B). In contrast,
the expression profile of reMAIT cells became more similar to
that of CB-MAIT cells as cells differentiated, resulting in an
increase in r values (Figure 4C). Heatmap analysis corroborated
these results (Figure S4). These data indicate that differentiation
of MAIT-iPSCs in vitro resulted in global gene-expression
profiles similar, but not identical, to that of CB-MAIT cells.
Characterization of reMAIT Cells
MAIT cells are distinguished from conventional CD4+ and CD8+
T cells by their ability to produce IFNg in the presence of
bacteria-fed monocytes. Thus, we assessed the capacity of
reMAIT cells to produce IFNg (Le Bourhis et al., 2010). Whereas
little IFNg was produced from noninfected monocytes in the
absence and presence of reMAIT cells, infection of the mono-
cytes with Escherichia coli (E. coli) resulted in IFNg production
that was further enhanced in the presence of reMAIT cells, as
demonstrated by enzyme-linked spot (ELISPOT) assay (Fig-
ure 5A). Bio-Plex analysis, which allows the simultaneous quan-
tification of an array of cytokines and chemokines, revealed that
the addition of reMAIT cells to E. coli-fed monocytes culminated
in both an 20-fold increase in IFNg production and enhanced
production of cytokines and chemokines such as IL-2, IL-17,
IL-10, IL-12p40, IL-12p70, tumor necrosis factor a (TNF-a), gran-
ulocyte macrophage colony stimulating factor (GM-CSF), induc-
ible protein 10 (IP-10; CXCL10), and monokine induced by IFNg
(MIG; CXCL9) (Figure 5B). MR1 antibody interfered with produc-
tion of the cytokines, implying that reMAIT cell function is MR1
dependent (Figure S5A). reMAIT cells exhibited enhanced
production of platelet-derived growth factor-binding protein,
IL-1a, IL-1b, IL-6, IL-13, basic fibroblast growth factor (bFGF),
granulocyte colony stimulating factor (G-CSF), IL-18, and TNF-
related apoptosis-inducing ligand during culture with E. coli-
fed monocytes (Table S3). CB-MAIT cells showed a similar
expression profile but exhibited enhanced production of a spec-
trum of the inflammatory chemokines, such as eotaxin (CCL11),
monocyte chemoattractant protein 1 (CCL2), macrophage
inflammatory protein 1a (MIP1a; CCL3), MIP1b (CCL4), and
the regulated-upon-activation, normal T cells expressed andCell Stem Cell 12, 546–558, May 2, 2013 ª2013 Elsevier Inc. 551
Figure 5. Characterization of reMAIT Cells
(A) ELISPOT assay for IFNg. PBMC-derived monocytes were left intact or infected with E. coli for 3 hr (upper and lower panels, respectively). These monocytes
were subjected to ELISPOT assay without or with reMAIT cells (left and right panels, respectively).
(B) Cytokines and chemokines produced by reMAIT cells. Supernatants from cocultures of E. coli-fed monocytes and reMAIT cells or intact monocytes and
reMAIT cells were subjected to Bio-Plex cytokine assay. LPL-reMAIT cells, reMAIT cells harvested from LPL in immunocompromisedmice. Results are shown as
the means ± SD of triplicate experiments.
(C) E. coli-fed monocytes promoted the production of IL-22 and IFNg. reMAIT cells were stimulated with monocytes or E. coli-fed monocytes, and intracellular
staining using antibodies against the indicated cytokines was performed. Left panels show isotype control staining. Data are representative of triplicate
determinations with similar results.
(D) reMAIT cells produce IFNg, IL-17A, and IL-22. reMAIT cells were left unstimulated (control) or stimulated with anti-CD3 and anti-CD28 beads or with PMA and
ionomycin, and intracellular staining with antibodies against the indicated cytokines was performed. The left panels show isotype-control staining. The numbers
in the quadrants are the percentages of the populations (C and D).
(E) Activation of reMAIT cells. CD69 expression is shown as a histogram. The shadow indicates the isotype-control staining. The dotted line shows the profile of an
untreated sample, whereas solid and bold lines indicate those of anti-CD3 and anti-CD28- or PMA- and ionomycin-treated samples, respectively. Representative
data from triplicate determinations are shown.
See also Figure S5 and Tables S3 and S4.
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cellular staining revealed that reMAIT cells harbored perforin
and granzyme A, effector molecules required for cytotoxic
activity (Figure 5C). Although challenge with E. coli-fed mono-
cytes did not significantly interfere with the expression of these
molecules, it did enhance the production of IL-22 and IFNg,
but not IL-21 (Figure 5C). Another hallmark of MAIT cells is
production of IL-17A and IFNg upon phorbol 12-myristate 13-
acetate (PMA) and ionomycin stimulation (Dusseaux et al.,
2011). Upon application of this stimulus, reMAIT cells produced
IL-17A and IFNg, as well as a lesser amount of IL-22, evidenced
by the intracellular staining (Figure 5D). Similarly, stimulation with552 Cell Stem Cell 12, 546–558, May 2, 2013 ª2013 Elsevier Inc.anti-CD3 and anti-CD28 induced IFNg (Figure 5D). reMAIT cells
were activated by both stimuli, evidenced by the upregulation of
CD69, an activation marker (Figure 5E). Bio-Plex analysis
demonstrated that reMAIT cells exhibited enhanced MIP1b
(CCL4), cutaneous T cell-attracting factor (CCL27), and MIG
(CXCL9) production by both stimuli (Table S4). Given that
reMAIT cells produced Th17 and T cytotoxic 17 (Tc17) cytokines
such as IL-17 and IL-22, expression of RORC, a transcription
factor important for Th17 and Tc17 cells, was evaluated. Most
reMAIT cells expressed RORC at the end of differentiation,
whereas little FOXP3 expression was detected (Figure S5B).
The above data show that reMAIT cells produce a spectrum of
Figure 6. reMAIT Cells in NOD/SCID Mice
(A) reMAIT cells in NOD/SCID mice. After adoptive transfer of reMAIT cells via intravenous injection, mice were sacrificed, and lymphocytes were prepared
from the indicated organs. Single lymphocytes were stained with 3C10 and a human TCRab antibody. Numbers represent the percentages of reMAIT cells
(3C10+TCRab+). Data are representative of at least six mice with similar results. Lymphocytes expressing both Va7.2 and human TCRabwere further analyzed in
terms of their expression of CD45RO and the indicated coreceptors (B–D).
(B) CCR2, CCR5, CCR6, CCR7, and CCR9 expression in reMAIT cells.
(C) CXCR3, CXCR4, CXCR5, CXCR6, and CXCR7 expression in reMAIT cells.
(D) CD62L, CD243, ICOS, IL-12Rb2, and IL-23R expression in reMAIT cells. Data are representative of six mice with similar results. The numbers in the quadrants
indicate the percentages of the populations.
See also Figure S6 and Tables S3 and S4.
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well as IFNg, upon stimulation.
reMAIT Cells in Immunocompromised Mice
Thus far, reMAIT cells possessed a similar but distinct pheno-
type compared to MAIT cells. We next determined whetherreMAIT cells could be established in immunocompromised
mice and migrate to the organs, as reported in humans
(Dusseaux et al., 2011). Upon adoptive transfer, reMAIT cells
(3C10+TCRab+) were identified in the bone marrow (BM),
liver mononuclear cells (LMCs), spleen, intraepithelial lympho-
cytes (IELs), and LPLs (Figures 6A and S6A). Intriguingly, theCell Stem Cell 12, 546–558, May 2, 2013 ª2013 Elsevier Inc. 553
Figure 7. reMAIT Cells Protect Mice from M. abscessus Infection
(A)M. abscessus in the liver and spleen of NOGmice. After adoptive transfer of
reMAIT cells, mice were challenged with M. abscessus intravenously. Two
weeks later, the organs were subjected to colony-forming assays. Small
horizontal lines indicate medians. *p < 0.01 (Student’s t test). Representative
data of two independent determinations are shown (n = 5–7 for the liver and
5–6 for the spleen).
(B) Release of granulysin from reMAIT cells. Mouse sera were subjected to
ELISA after M. abscessus infection. n = 3. p < 0.1 (Student’s t test).
Control mice received no reMAIT cells (control), whereas other mice received
reMAIT cells prior to infection (+reMAIT). See also Figure S7.
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TCRab + cells) was drastically changed (Figures 6B–6D, S6B,
and S6C). reMAIT cells in LMCs acquired a typical Th17 pheno-
type harboring CCR6, IL-12Rb2, and IL-23R (Figures 6B and 6D).
Concomitantly, the overall expression profiles of chemokine
receptors in the organs reflected those required for their homing
(Figures 3C, S3B, 6B, and 6C). Levels of naive T cell markers
such as CD45RA and CD62L were downregulated (Figures 3E
and 6D). Furthermore, the expression of CD26, CD95, CD244,
and IL-18Ra was decreased (Figures 3D, 3E, S6B, and S6C).
It is noteworthy that CD243 expression was evident in LMCs,
whereas ICOS expression persisted in LPLs (Figure 6D). When
reMAIT cells from LPLs (LPL-reMAIT cells) were subjected
to bacterial challenge, they produced a similar spectrum of
cytokines as did CB-MAIT cells but little IP-10 (CXCL10) and
MIG (CXCL9) as compared with the control (Figure 5B and
Table S3). PMA and ionomycin stimuli also engendered the
production of a similar but distinct panoply of the cytokines
and chemokines (Tables S4). These data indicate that reMAIT
cells settle and mature to a certain degree in the immunocom-
promised mouse.
reMAIT Cells Protect Mice from Mycobacterium
Infection
The above data suggested that reMAIT cells could exert antimy-
cobacterial activity in a manner similar to MAIT cells (Chua
et al., 2012; Le Bourhis et al., 2010). We therefore assessed
the role of reMAIT cells in a mycobacterial infection model using
M. abscessus (Rottman et al., 2007). reMAIT cells were adop-
tively transferred to immunocompromised mice followed by554 Cell Stem Cell 12, 546–558, May 2, 2013 ª2013 Elsevier Inc.M. abscessus inoculation. The resulting bacterial loads of organs
were then measured. Without cell transfer, mice had a high
bacterial load in the spleen and liver. In contrast, adoptive
transfer of reMAIT cells lowered bacterial load in these organs,
conferring a 40%–50% reduction in colony-forming units (cfu)
as compared with the controls (Figure 7A). Dendritic cells
(DCs) transferred before M. abscessus inoculation did not
protect mice (Figure S7A). To elucidate the mechanism by which
reMAIT cells exert antimycobacterial activity, mouse sera were
analyzed by ELISA. M. abscessus infection induced the release
of granulysin, whereas neither IFNg nor TNF-a was detected
(Figure 7B, data not shown). Accordingly, in vitro experiments
indicated that bacterial infection triggered the release of granu-
lysin from reMAIT cells (Figure S7B). The data demonstrate
that reMAIT cells exert antimycobacterial activity in vivo and
suggest that granulysin, a saposin-like family gene member, is
an effector molecule responsible for combating intracellular
bacteria (Krensky and Clayberger, 2009).
DISCUSSION
Generation of MAIT-iPSCs
Although iPSCs from T cells have been reported, use of the SeV
vector assures generation of genome-modification-free iPSCs
(Fusaki et al., 2009; Loh et al., 2010; Nishimura et al., 2011; Nish-
imura et al., 2013; Seki et al., 2010; Staerk et al., 2010; Vizcardo
et al., 2013). Most importantly, our data demonstrated that
SeV KOSM302L infects nonproliferating cells, such as MAIT
cells, and generates iPSCs. Furthermore, the fact that most of
the iPSCs obtained with this vector originated from MAIT cells,
regardless of the presence of other lymphocytes, suggest
a strong tropism of the vector for MAIT cells, although the under-
lying mechanisms have yet to be elucidated.
reMAIT Cell Induction from MAIT-iPSCs
Because T cells have been derived from CD34hiCD43int cells
when differentiated from human ESCs, we adapted this protocol
to generate reMAIT cells (Timmermans et al., 2009) (Figures 3A
and 3B). Remarkably, more than 98% of the lymphocytes were
3C10+ and TCRab+ with concomitant expression of CD161
and IL-18Ra, a prerequisite of MAIT cells (Le Bourhis et al.,
2010). The expression of CD4 and CD8a implied that reMAIT
cells represented an immature T cell (Figure 3B). Given that
T cells induced from hematopoietic stem cells or ESCs give
rise to polyclonal double-positive T cells, but few 3C10+ cells,
the in-frame rearranged invariant TCRa loci should play a pivotal
role in the destiny of T cells from MAIT-iPSCs (Figures 1A, 3B,
and S3A) (Schmitt et al., 2004; Timmermans et al., 2009; H.W.,
unpublished data). Accordingly, antigen-specific T cells’ rediffer-
entiation from iPSCs results in less efficient generation of the
original cells as compared with our current data (Nishimura
et al., 2013; Vizcardo et al., 2013). This is similar to the situation
regarding NKT cell induction from cloned ESCs, in which the
presence of the in-frame rearranged Va14-Ja18 TCRa specific
for murine NKT cells in the allele yields highly homogenous
NKT cells (>92%) (Wakao et al., 2008). At present, the molecular
mechanisms underlying the above phenomena remain enig-
matic, but it is tempting to speculate that epigenetic modifica-
tions, such as methylation and/or acetylation, occur in confined
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culminates in inhibition of a further rearrangement of the invariant
TCRa chain.
reMAIT Cells in Response to the External Cues
Adoptive transfer of reMAIT cells revealed intriguing facets
regarding the expression of homing receptors. The decrease of
CCR6 and CXCR5, concomitant with the increase of CXCR3
and CXCR6, indicated that the liver and/or intestine homing-
receptor expression is not a predetermined event; rather, it is
an inducible one (Figures 3C, S3B, 6B, and 6C). Because
CCR9 and CXCR6, as well as CXCR3, are required for lympho-
cyte trafficking to the liver and/or intestine, our data further
support their role in homing (Freeman et al., 2007; Geissmann
et al., 2005; Sato et al., 2005; Stenstad et al., 2006; Zabel
et al., 1999). In contrast, CD27 and CD28, expressed at high
levels in PBMC-MAIT cells, were not induced, suggesting that
environmental cues alone in the mice are not sufficient to effec-
tively induce the molecules (Figures S3D and S6B). Given that
MAIT cells interact with many other cell types, such as mono-
cytes, DCs, macrophages, epithelial and fibroblastic cells, and
probably B cells, further investigation is warranted for identifying
cells or stimuli, such as infection or stress, that culminate in the
induction of these molecules. Global gene-expression analyses
of reMAIT cells uncovered the time-dependent maturation of
the cells (Figures 4B, 4C, and S4). The r value of 0.918 between
day 30 gene expression in reMAIT cells and CB-MAIT cells
suggests that they harbor similar but distinct gene-expression
profiles (Figures 4C and S4).
The functionality of reMAIT cells is characterized by their
production of various cytokines and chemokines (Figures 5A–
5D and S5A and Tables S3 and S4). Culturing with E. coli-fed
monocytes stimulated the production of cytokines known to
play a protective role against bacterial infection, such as IFNg
and TNF-a (Figures 5A and 5B). Production of IL-2, IL-10, and
IL-17 upon bacterial challenge was in line with a previous report,
although the level of background production in reMAIT cells was
relatively high compared with that in CB-MAIT cells (Dusseaux
et al., 2011) (Figure 5B). This may reflect the difference in the
maturation states between CB-MAIT and reMAIT cells. Accord-
ingly, enhanced production of IFNg, IP-10 (CXCL10), and MIG
(CXCL9) with a high background was identified for reMAIT cells
only (Figure 5B). LPL-reMAIT cells behaved similarly to CB-
MAIT cells in terms of cytokine production, suggesting that
reMAIT cells matured to a certain degree in mice, but not to
the same level as CB-MAIT cells (Figure 5B). IL-22 production
suggests that reMAIT cells per se trigger antibacterial activity
by inducing antibacterial proteins produced by epithelial cells,
such as b-defensins, S100 calcium-binding proteins, regenerat-
ing-gene family proteins, and lipocalin-2 (Figure 5C) (Colonna,
2009). The immediate release of granulysin in sera upon infection
suggests that reMAIT cells exert direct M. abscessus killing as
previously shown for Mtb, although the detailed mechanism
has yet to be determined (Figure 7B) (Stenger et al., 1998).
Because granulysin is specific to humans and no homolog is
found in mice, the use of reMAIT cells sheds light on the mech-
anism of host immune defense in humans. As reMAIT cells
express CCR6, IL-12Rb2, IL-23R, RORC, IL-17, IL-22, and
probably IL-23, MAIT cells may be a subset of Th or Tc17 cellsor a novel family of lymphoid-tissue-inducer cells with an immu-
noregulatory function (Figures 5B–5D and S5B) (Colonna, 2009).
Further research into the role of MAIT cells in health and disease
is warranted.
NKT and MAIT cells are representative invariant T cells in
mammals. The hallmark of these cells is expression of an
invariant TCR and NK cell markers. Human NKT cells express
Va24-Ja18, whereas human MAIT cells harbor Va7.2-Ja33
(Le Bourhis et al., 2011). NKT cells play a pivotal role in the
immune system, because they enhance or suppress the immune
response through rapid secretion of cytokines (Bendelac et al.,
2007). In this regard, NKT cells are considered an innate-type
immune cell. Another common feature of NKT and MAIT cells
is that their development is not contingent uponMHCmolecules.
Development of NKT cells depends on the nonpolymorphic
molecule CD1d, whereas that of MAIT cells is dependent on
MR1. Although the invariant TCR for both cell types is phyloge-
netically conserved, they possess different characteristics.
NKT cells are abundant in mice, whereas MAIT cells are more
numerous in humans (Dusseaux et al., 2011). Their develop-
mental pathways also seem to be distinct. NKT cells emigrate
from the thymus as mature innate-type T cells, for they are
selected, expand, and develop the innate-like phenotype and
function in the thymus. In contrast, MAIT cells are naive and
less abundant in the thymus, and the Va7.2-Ja33 messenger
RNA level is low in CB, yet they are quite abundant in adults
and represent an effector memory phenotype (Tilloy et al.,
1999; Walker et al., 2012). NKT cell development is dependent
on SLAM and the SLAM-associated protein (SAP)-Fyn pathway,
whereas that of MAIT cells is not (Le Bourhis et al., 2011).
Patients who lack SAP show no aberrancy in MAIT cell number
(Martin et al., 2009). NKT cells expand ex vivo upon the addition
of an agonist such as a-galactosylceramide, whereas no
mitogen for MAIT cells has been reported to date (Bendelac
et al., 2007; Le Bourhis et al., 2011). Given that MAIT cells
residing in adult PBMCs are not cycling, it is plausible that
MAIT cells cease to proliferate within several years after birth
(Dusseaux et al., 2011; Walker et al., 2012). Nonetheless,
the possibility of an occasional expansion of the cells due to
infection or aberrant activation cannot be excluded. Though
no reMAIT cell proliferation was observed during in vitro dif-
ferentiation, it is probable that some stimuli present in immu-
nocompromised mice function as a mitogen for reMAIT cells
given that they do proliferate in vivo (data not shown). This is
most likely due to the presence of commensal flora in the gut
(Treiner et al., 2003). An endogenous ligand for MAIT cells can
be eluted with acid and may include a peptide moiety, given
that peptidase treatment abolishes the putative activity in the
delipidated Mtb cell-wall fraction (Gold et al., 2010; Huang
et al., 2009). Intriguingly, putative ligand(s) transduce signals in
a manner independent of the TLR. Indeed, blocking of TLR2
and/or TLR4 signaling or ablation of TLR9 signaling does not
interfere with the production of IFNg or with activation induced
upon contact between MAIT cells and Mtb- or E. coli-infected
DCs (Gold et al., 2010; Le Bourhis et al., 2010). Similarly, Nod-
like receptors play a marginal role in MAIT cell activation (Le
Bourhis et al., 2010). Recently, however, vitamin B metabolites
were shown to bind to MR1, activate MAIT cells, and stimulate
production of IFNg and TNF-a (Kjer-Nielsen et al., 2012). It isCell Stem Cell 12, 546–558, May 2, 2013 ª2013 Elsevier Inc. 555
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a TLR and/or Nod-like receptor signal. In contrast, NKT cells are
activated by lipopolysaccharide or bacterial CpG via TLR4 or
TLR9, respectively, in antigen-presenting cells (APCs) and
produce IFNg (Kronenberg and Kinjo, 2009). The components
involved in MAIT cell-ligand signaling as downstream molecules
ofMR1 in APCs have yet to be determined, but their identification
will facilitate further study of human innate immunity.
In conclusion, we established genome-modification-free
iPSCs from human MAIT cells and succeeded in the highly
selective differentiation of MAIT-like cells without ectopic gene
expression. These cells produced a wide range of cytokines
and chemokines and alleviated the mycobacterial burden in
mice. These data pave the way for the realization of the promise
of cell therapy and regenerative medicine using iPSCs.
EXPERIMENTAL PROCEDURES
Isolation of MAIT Cells from CB
CB was obtained with informed consent at the Hokkaido University hospital.
Mononuclear cells were prepared from CB using Ficoll solution and washed
extensively with PBS. MAIT cells were purified as 3C10+ cells with biotinylated
monoclonal antibody 3C10 using two consecutive magnetic-activated cell
sorting (MACS) columns. The purity of the 3C10+ cells after the second column
was >96% from donor 1, >88% from donor 2, and >78% from donor 3, as
determined by FACS analysis.
Reprogramming of 3C10+ Cells with SeV Vector
3C10+ cells (23 105) were infected with the KOSM302L vector at a multiplicity
of infection of 2.5 for 2 hr at room temperature in Hank’s balanced salt solution
(Nishimura et al., 2013) (Invitrogen, Grand Island, NY, USA). After infection, the
virus-containing solution was removed by brief centrifugation, and cells were
suspended in ESC medium containing 1:1 Dulbecco’s modified Eagle’s
medium/F-12 (Sigma-Aldrich, Tokyo), 20% knockout-replacement serum
(Invitrogen), 13 nonessential amino acids (Sigma-Aldrich), 2 mM glutamine
(Invitrogen), 0.1 mM b-mercaptoethanol (Sigma-Aldrich), and 4 ng/ml bFGF
(PeproTech, Rocky Hill, NJ, USA). The resultant cells were transferred to
6-well plates filled with mitomycin (MMC)-treated mouse embryonic fibro-
blasts (MEFs) and cultured at 37C in 5% CO2 with a medium change every
other day. Colonies were picked 12 days postinfection and subjected to
0.25% trypsin-0.02% EDTA (Sigma-Aldrich) digestion. Cells from each colony
were seeded individually in 24-well plates containing MMC-treated MEFs.
Colonies that showed an iPSC-like morphology were subjected to further
analysis. In some cases, colonies were treated with small interfering RNA
(siRNA) for accelerating eradication of the SeV. iPSC clones 1-3D, 2-5D, and
4-6D were generated without siRNA treatment.
Differentiation of MAIT-iPSCs into 3C10+TCRab+IL-18Ra+CD161+
Cells
Differentiation of MAIT-iPSCs into 3C10+TCRab+IL-18Ra+CD161+ cells was
achieved in two steps. The first step required induction of CD34+CD43+ cells.
In brief, 1.0 3 106 fragmented MAIT-iPSCs were seeded on 3–6 days post-
confluent OP9 (gelatin-coated 10 cm plastic dish) in differentiation medium
(aMEM supplemented with 10% fetal bovine serum [Invitrogen] plus100 mM
1-thioglycerol [Sigma-Aldrich]). Half of the medium was changed 4 days
later and then on days 6, 8, and 10. On day 11, the differentiated cells were
harvested, and CD34+CD43+ cells were purified. The second step comprised
culture of these cells on OP9/DL1. For additional details, see the Supplemental
Experimental Procedures.
Cytokine Production Assay
reMAIT cells differentiated for 4 weeks on OP9/DL1 were stimulated with
anti-CD3/CD28 magnetic beads according to the manufacturer’s instructions
(Invitrogen), or with PMA and ionomycin (10 ng/ml/1 mM, respectively, Wako
Chemicals, Osaka, Japan) for16 hr, and the production of IFNg, IL-17A,556 Cell Stem Cell 12, 546–558, May 2, 2013 ª2013 Elsevier Inc.IL-21, and IL-22 was assessed by intracellular staining together with the
expression of the activation marker CD69. Cytokine production was assessed
by incubating reMAIT cells with E. coli-fed monocytes prepared from PBMCs,
as described previously (Le Bourhis et al., 2010). When assessing the effect
of MR1 on cytokine production, control antibody (mouse immunoglobulin
Gk), or MR1 antibody (2.0 mg/ml) was preincubated with E. coli-fed monocytes
prior to the addition of reMAIT cells or CB-MAIT cells. The supernatant was
harvested 10 hr later and subjected to Bio-Plex analysis. IFNg production
was visualized with ELISPOT (Oxford Immunotec, Oxford), and the cytokine
and chemokine concentrations were measured with Bio-Plex Immunoassays,
Pro Human Cytokine 21-plex Assay, and Pro Human Cytokine 27-plex Assay
(Bio-Rad, Tokyo). In brief, 1.03 104 monocytes or E. coli-fed monocytes were
cultured with 20,000 reMAIT cells, CB-MAIT cells, and reMAIT cells from
LPLs (LPL-reMAIT cells) for 48 hr and subjected to Bio-Plex assay. LPL-
reMAIT cells were prepared from the intestines of reMAIT cell-injected NOD/
SCID mice using phycoerythrin (PE)-conjugated anti-human CXCR3
(hCXCR3), followed by anti-PE microbeads. The purity of the hCXCR3+ cells
was 80% after MACS column, as determined by FACS analysis. CB-MAIT
cells were those fromCB that were 3C10+ (purity >95%). Cytokine and chemo-
kine production upon anti-CD3 and anti-CD28 or PMA and ionomycin stimu-
lation of an identical number of reMAIT cells, CB-MAIT cells, and LPL-reMAIT
cells was assessed using the Bio-Plex system, as described above.
M. abscessus Infection
Seven-week-old female NOD/shi-scid, IL-2RgKOJic (NOG) mice (JAPAN
Clear, Shizuoka, Japan) were injected intravenously with 5.03 104 (for the liver
cfu measurement) or 2.0 3 105 reMAIT cells (for the spleen cfu measurement)
from culture day 30 when the purity of cells was >95%, as determined by
3C10 and TCRab staining, or were left untreated. Five weeks later, mice
were injected intravenously with 1.0 3 106 cfu of M. abscessus or left
untreated. Mice were sacrificed 14 days later, and cfu in the whole liver and
spleen were determined (Rottman et al., 2007). Sera were recovered from
mice 20 hr afterM. abscessus infection and subjected to ELISA for granulysin
(USCN Life Science, Wuhan, China), human IFNg (Bio-Rad), and TNF-a (Bio-
Rad). For ELISA, mice received 5.03 104 reMAIT cells 5 days prior to infection.
Statisitcs
All data are presented as means ± SD and were processed using the Excel
program (Microsoft), applying two-tailed Student’s t test. p values <0.05
were considered significant.
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